Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2011

Open Access 01-02-2011 | Clinical Practice: Clinical Images

Concurrent Sweet’s Syndrome and Erythema Nodosum

Authors: Tracie Harris, MD, Mark C. Henderson, MD

Published in: Journal of General Internal Medicine | Issue 2/2011

Login to get access

Excerpt

A 29-year-old Mexican man was admitted to the hospital with fever, cough, sore throat, and red, tender leg nodules suggestive of erythema nodosum (Fig. 1). The white blood cell count was 35,000. Several days later, annular plaques and pustules developed on his face, neck, and forearms (Figs. 2 and 3). Facial skin biopsy showed neutrophilic dermatitis without evidence of infection or vasculitis consistent with Sweet’s syndrome. Biopsy of the thigh was non-diagnostic, but showed a mixed neutrophilic and granulomatous dermatitis.
Metadata
Title
Concurrent Sweet’s Syndrome and Erythema Nodosum
Authors
Tracie Harris, MD
Mark C. Henderson, MD
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1536-1

Other articles of this Issue 2/2011

Journal of General Internal Medicine 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine